Byongen Therapeutics
PrivateLast Round
VC Round
Sep 18, 2023
Total Funding Raised
$4.7M
Company Overview
Byongen Therapeutics is a biotechnology company that specializes in original gene delivery innovations, specifically focusing on AAV capsid engineering to develop safer and more efficient gene therapies.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Byongen Therapeutics Comparables
Compare Byongen Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Dyno Therapeutics | 86% | |
| Lir Therapeutics | 84% | |
| rAAVen Therapeutics | 84% |
Byongen Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Sep 18, 2023 | ||||
| Pre Seed | Mar 4, 2022 |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 18, 2023
Raised $14M in a venture round.
- Mar 4, 2022
$4.7M raised in Pre Seed round.
Byongen Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Byongen Therapeutics's valuation, stock price, and market status.
Is Byongen Therapeutics a public or private company?
Byongen Therapeutics is a private company.
What is the current stock price of Byongen Therapeutics?
Byongen Therapeutics is a private company with no public stock price. Caplight tracks Byongen Therapeutics's secondary market activity and provides MarketPrice™ estimates to Caplight users.
How much is Byongen Therapeutics worth (valuation)?
Valuation information for Byongen Therapeutics is not publicly available.
Can I buy Byongen Therapeutics stock?
Byongen Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Byongen Therapeutics's last funding round?
Byongen Therapeutics's most recent funding round was VC Round on September 18, 2023.
Who are the main investors in Byongen Therapeutics?
Investor information for Byongen Therapeutics is not publicly disclosed.
Will Byongen Therapeutics IPO soon?
No public IPO plans have been announced for Byongen Therapeutics.
How can I track Byongen Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Byongen Therapeutics's secondary market activity and sign up for updates.